CA2387394C - Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder - Google Patents

Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder Download PDF

Info

Publication number
CA2387394C
CA2387394C CA002387394A CA2387394A CA2387394C CA 2387394 C CA2387394 C CA 2387394C CA 002387394 A CA002387394 A CA 002387394A CA 2387394 A CA2387394 A CA 2387394A CA 2387394 C CA2387394 C CA 2387394C
Authority
CA
Canada
Prior art keywords
aminoindan
control
salt
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002387394A
Other languages
English (en)
French (fr)
Other versions
CA2387394A1 (en
Inventor
Gabriela Barak
Ruth Levy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceutical Industries Ltd
Original Assignee
Teva Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd filed Critical Teva Pharmaceutical Industries Ltd
Publication of CA2387394A1 publication Critical patent/CA2387394A1/en
Application granted granted Critical
Publication of CA2387394C publication Critical patent/CA2387394C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002387394A 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder Expired - Fee Related CA2387394C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16181799P 1999-10-27 1999-10-27
US60/161,817 1999-10-27
PCT/US2000/029618 WO2001030339A1 (en) 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

Publications (2)

Publication Number Publication Date
CA2387394A1 CA2387394A1 (en) 2001-05-03
CA2387394C true CA2387394C (en) 2009-08-18

Family

ID=22582876

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002387394A Expired - Fee Related CA2387394C (en) 1999-10-27 2000-10-27 Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

Country Status (9)

Country Link
US (1) US6492426B1 (https=)
EP (1) EP1242066B1 (https=)
JP (1) JP2003512426A (https=)
AT (1) ATE331508T1 (https=)
AU (1) AU775885B2 (https=)
CA (1) CA2387394C (https=)
DE (1) DE60029131T2 (https=)
IL (2) IL149308A0 (https=)
WO (1) WO2001030339A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1200315A1 (en) 2011-10-10 2015-08-07 Teva Pharmaceutical Industries Ltd. R(+)-n-formyl-propargyl-aminoindan
US9181026B2 (en) 2013-10-03 2015-11-10 Custom Chemical Solutions, LLC Containment berm with internal “L” braces
WO2024196698A2 (en) * 2023-03-17 2024-09-26 Curadh Mtr Compounds and constructs useful for targeting fibroblast activation protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB852735A (en) 1956-04-13 1960-11-02 Schering Ag Manufacture of 1-aminoindanes
US3637740A (en) * 1969-04-21 1972-01-25 Pfizer Aminobenzocycloalkane compounds
BE786748A (fr) 1971-07-26 1973-01-26 Basf Ag 1-aminomethyl-indanes-n-substitues
US4096173A (en) * 1977-03-28 1978-06-20 Eli Lilly And Company Chlorinated 1-aminoindane N-methyl transferase inhibitors
JPS5824433A (ja) * 1981-08-06 1983-02-14 Takehiro Mokuzai Kogyo Kk 繊維材成型品の表面化粧方法
DE3407842A1 (de) 1983-03-04 1984-09-06 Otsuka Pharmaceutical Co. Ltd., Tokyo Indanderivate und deren salze, verfahren zu deren herstellung und arzneimittel und antioxidationsmittel, welche diese enthalten
US5242919A (en) 1984-08-31 1993-09-07 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1H-indene derivatives
JPS6169747A (ja) 1984-08-31 1986-04-10 Otsuka Pharmaceut Co Ltd ２，３―ジヒドロ―１ｈ―インデン誘導体及びその製造法
DE3583780D1 (de) 1984-08-31 1991-09-19 Otsuka Pharma Co Ltd 2,3-dihydro-1h-inden-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4882339A (en) 1987-07-10 1989-11-21 Ciba-Geigy Corporation 4-Amino-substituted 1,2-dihydroxynaphthalene derivatives useful in inhibiting 5-lipoxygenase activity in mammals
IL92952A (en) 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
IL99759A (en) 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
US5344836A (en) 1991-11-11 1994-09-06 Ono Pharmaceutical Co., Ltd. Fused benzeneoxyacetic acid derivatives
CH683996A5 (fr) 1992-03-05 1994-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
ATE219766T1 (de) 1993-04-07 2002-07-15 Otsuka Pharma Co Ltd N-acylierte 4-aminopiperidin derivate als aktive bestandteile von peripher gefässerweiternden wikstoffen
IL111240A (en) 1993-10-18 2001-10-31 Teva Pharma Salts of r(+) - enantiomers of n- propargyl-1-aminoindan and pharmaceutical compositions comprising them
US5877218A (en) 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
EP0738149B1 (en) * 1994-01-10 2006-11-29 Teva Pharmaceutical Industries, Ltd. 1-aminoindan derivatives and compositions thereof
CH690264A5 (fr) 1995-06-30 2000-06-30 Symphar Sa Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
US5646188A (en) 1995-07-05 1997-07-08 Teva Pharmaceutical Industries, Ltd. Polyamine derivatives of 1-aminoindan
IL115357A (en) 1995-09-20 2000-01-31 Teva Pharma Stable compositions containing N-propargyl-1-aminoindan and polyhydric alcohols
US5887218A (en) 1996-06-10 1999-03-23 Ricoh Co., Ltd. Color image forming apparatus having toner and transfer sheet bearing members and image forming method thereof
ES2241064T3 (es) 1996-12-18 2005-10-16 Teva Pharmaceutical Industries, Ltd. Derivados de aminoindano.
US6251938B1 (en) 1996-12-18 2001-06-26 Teva Pharmaceutical Industries, Ltd., Phenylethylamine derivatives
WO1998055447A1 (en) 1997-06-05 1998-12-10 Venantius Limited 3-aminoindane derivatives, process for their preparation and pharmaceutical compositions containing them
US5887221A (en) 1997-10-20 1999-03-23 Xerox Corporation Signature sensing for optimum toner control with donor roll
US6227886B1 (en) 1999-04-16 2001-05-08 Avaya Technology Corp. Snag-resistant patchcord plug latch and cover

Also Published As

Publication number Publication date
DE60029131T2 (de) 2007-01-18
WO2001030339A1 (en) 2001-05-03
EP1242066A4 (en) 2004-09-01
EP1242066B1 (en) 2006-06-28
JP2003512426A (ja) 2003-04-02
EP1242066A1 (en) 2002-09-25
AU1440201A (en) 2001-05-08
CA2387394A1 (en) 2001-05-03
AU775885B2 (en) 2004-08-19
IL149308A (en) 2007-07-24
IL149308A0 (en) 2002-11-10
DE60029131D1 (de) 2006-08-10
US6492426B1 (en) 2002-12-10
ATE331508T1 (de) 2006-07-15

Similar Documents

Publication Publication Date Title
JP4782252B2 (ja) １−アミノインダン及びこれらの組成物
US8883808B2 (en) Combination of 5-HT7 receptor antagonist and serotonin reuptake inhibitor therapy
KR20100050502A (ko) 도파민계가 붕괴되어 있는 장애 또는 병태의 증상을 감소 또는 치료하기 위한 ｋｃｎｑ 포타슘 채널 개방제의 용도
EP2283833A2 (en) Amines and amides for the treatment of diseases
BR112019020798A2 (pt) métodos e composições para tratamento de danos associados ao envelhecimento usando inibidores de ccr3
KR20010024076A (ko) 5-ＨＴ 재흡수 억제제 및 ｈ5-ＨＴ1Ｂ 길항제 또는 부분작용제의 배합물
US20120046302A1 (en) Methods of treating cns disorders
CA2387394C (en) Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder
US20050119285A1 (en) Treatment of neurological disorders related to rapid eye movement (REM) sleep disturbances with NPY Y5 receptor antagonists
WO2010126527A1 (en) Methods of treating cns disorders
CA2508546A1 (en) Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
Cramer et al. Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse
Mahaney et al. Structure− Activity Relationships of the Cycloalkanol Ethylamine Scaffold: Discovery of Selective Norepinephrine Reuptake Inhibitors
CN112367998B (zh) 用组胺-3受体反向激动剂进行治疗的方法
KR20010024075A (ko) 선택적 5-ＨＴ1Ａ 길항제 및 선택적 ｈ5-ＨＴ1Ｂ 길항제또는 부분 작용제의 배합물
JP4362367B2 (ja) 神経因性疼痛および群発および偏頭痛に伴う疼痛の防止または処置に使用するためのカルバメート化合物
US20040254173A1 (en) Modulation of dopamine responses with substituted (S)-2,3-benzodiazepines
WO2025254130A1 (ja) 遺伝子発現制御剤
AU2006209368A1 (en) New association between agomelatine and a noradrenaline reuptake inhibitor and pharmaceutical compositions containing it
RS4504A (sr) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju neuropatskog bola u vezi sa klasterskim i migrenskim glavoboljama
BR112020024264B1 (pt) Uso de um agonista inverso do receptor de histamina-3 para a fabricação de um medicamento e uso de uma composição farmacêutica
HK1129593B (en) Use of kcnq-opener for the preparation of a pharmaceutical composition for treating schizophrenia
HK1129593A1 (en) Use of kcnq-opener for the preparation of a pharmaceutical composition for treating schizophrenia
HK1153672A (en) Amines and amides for the treatment of diseases
RU2007109791A (ru) Антагонисты 5-нт7 рецепторов

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed